Deciphera Pharmaceuticals Inc. (DCPH)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Redmile Group

Jeremy Green

4,244,721 $155,399 -3% 2.29%
2.
OrbiMed Advisors

Samuel Isaly

3,297,301 $120,714 +139% 1.22%
3.
Deerfield Management

James E. Flynn

1,343,560 $49,188 +155% 0.87%
4.
Logos Capital

Arsani William

1,100,000 $40,271 +1675% 3.38%
5.
VenBio Select Advisor

Kurt Von Emster

1,068,000 $39,099 +20% 0.68%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$17.00 375,000 Large Shareholder 2,146,308 2017-10-02 Filing
$17.00 375,000 Large Shareholder, Director 2,146,308 2017-10-02 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$46.75 300 Director 0 2021-05-03 Filing
$46.07 7,700 Director 300 2021-05-03 Filing
$45.60 1,700 Director 0 2021-04-20 Filing
$46.66 1,300 Director 0 2021-04-19 Filing
$46.13 4,000 Director 1,300 2021-04-19 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 392,978 $14,386,925 0%
2. 8,866 $324,584 0%
3. 3,927,704 $143,794 0%
4. 3,056,213 $111,888 0.04%
5. 2,050,834 $75,081 0%
News See All